Diversion Quarterly — Q3 2020
Diversion Quarterly — Q3 2020
Kit Check is sharing data from its Bluesight™ for Controlled Substances platform on a quarterly…
Using AI to Prevent Diversion, Improve Efficiency, and Ensure Safety
A recent Pharmacy Technology Report article highlighted how Kit Check partner Children’s Hospital of the …
Kit Check Hospital Pharmacy Operations Report Reveals Over a Third of Hospital Pharmacy Professionals Are Aware of at Least One Colleague Who Has Stolen Controlled Substances
Report shows diversion, shortages, and patient safety among top priorities for pharmacy personnel WASHINGTON (APRIL …
Bluesight Med Tracking in the Fight Against COVID-19
Every day brings new information about the fight against the COVID-19 virus. Last week it …
Bluesight for Controlled Substances featured in Quartz article about the role of tech in combating the opioid crisis
The nation is in the grip of a tragic opioid crisis, and drugs that are …
Kit Check’s Agreement with Vizient Extended in Multi-Year Contract, Providing Better Visibility in Drug Diversion and Medication Tracking
WASHINGTON (October 3, 2019) — Kit Check, the leader in automated medication management solutions for …
Kit Check’s Bluesight for Controlled Substances™ Recognized by KLAS as Leading Emerging Solution for Drug Diversion Monitoring
Bluesight for Controlled Substances heralded in industry report, earns rating of 93.2 out of 100 …
Identifying Diversion by Location — A Practical Application of Machine Learning
In the day-to-day battle against drug diversion, most solutions look at the data to find …
Children’s Hospital of the King’s Daughters Closes Gap in Medication Diversion Controls with Bluesight for Controlled Substances
Children’s Hospital of the King’s Daughters (CHKD) in Virginia is not unlike most hospitals in …
What to see at ASHP mid-year 2017
ASHP Mid-Year kicks off on Sunday. As the biggest hospital pharmacy event of the year,…